CYTK
Cytokinetics, IncorporatedHealthcare$66.73
▲ Bullish
Mkt Cap: $8.22B|Float: 122.3M|SI: 12.8%|DTC: 8.6
Data as of market close Apr 2, 2026
IV Rank
91
IV Pctl
78%
HV 20d
37.8%
52W Range
$29-$71
ATR(14)
$2.69
Exp. Move
±23.4%
P/C Ratio
0.31
Earnings
May 6
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
CYTK Key Options Data
- IV Rank
- 90.8%
- Total GEX
- $0.01B
- Total DEX
- $5.9M
- Max Pain
- $60.00
- Expected Move
- ±23.4%
- Put/Call OI
- 0.31
- Net Premium
- $3.8M
- Spot Price
- $66.73
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$15.60 | ±23.4% | $51.13 | $82.33 |
| 2026-05-15 | 43 | ±$29.70 | ±44.5% | $37.03 | $96.43 |
| 2026-06-18 | 77 | ±$29.95 | ±44.9% | $36.78 | $96.68 |
| 2026-07-17 | 106 | ±$31.15 | ±46.7% | $35.58 | $97.88 |
| 2026-08-21 | 141 | ±$32.50 | ±48.7% | $34.23 | $99.23 |
| 2026-11-20 | 232 | ±$36.45 | ±54.6% | $30.28 | $103.18 |
Explore CYTK options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.